Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (DE:TD5A)
BERLIN:TD5A
Tandem Diabetes Care (TD5A) Stock Price & Analysis
1 Followers
TD5A Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€13.24 - €38.74
Previous Close€32.06
Volume0.00
Average Volume (3M)137.00
Market Cap
€2.15B
Enterprise Value€2.08B
Total Cash (Recent Filing)$498.16M
Total Debt (Recent Filing)$418.21M
Price to Earnings (P/E)N/A
Beta1.25
Next Earnings
May 01, 2024EPS Estimate
-€0.71Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding65,631,041
10 Day Avg. Volume0
30 Day Avg. Volume137
Standard Deviation0.21
R-Squared0.00244
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)7.39
Price to Sales (P/S)6.57
Price to Cash Flow (P/CF)-80.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.69
Enterprise Value/Gross Profit5.03
Enterprise Value/Ebitda-13.00
Forecast
1Y Price Target
€30.54Price Target Upside-4.74% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Tandem Diabetes Care News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
49.75% Other Institutional Investors
50.25% Public Companies and
Individual Investors
TD5A FAQ
What was Tandem Diabetes Care’s price range in the past 12 months?
Tandem Diabetes Care lowest stock price was €13.24 and its highest was €38.74 in the past 12 months.
What is Tandem Diabetes Care’s market cap?
Currently, no data Available
When is Tandem Diabetes Care’s upcoming earnings report date?
Tandem Diabetes Care’s upcoming earnings report date is May 01, 2024 which is 5 days ago.
How were Tandem Diabetes Care’s earnings last quarter?
Tandem Diabetes Care released its earnings results on Feb 21, 2024. The company reported -€0.427 earnings per share for the quarter, missing the consensus estimate of -€0.251 by -€0.176.
Is Tandem Diabetes Care overvalued?
According to Wall Street analysts Tandem Diabetes Care’s price is currently Overvalued.
Does Tandem Diabetes Care pay dividends?
Tandem Diabetes Care does not currently pay dividends.
What is Tandem Diabetes Care’s EPS estimate?
Tandem Diabetes Care’s EPS estimate is -€0.71.
How many shares outstanding does Tandem Diabetes Care have?
Currently, no data Available
What happened to Tandem Diabetes Care’s price movement after its last earnings report?
Tandem Diabetes Care reported an EPS of -€0.427 in its last earnings report, missing expectations of -€0.251. Following the earnings report the stock price went down -2.588%.
Which hedge fund is a major shareholder of Tandem Diabetes Care?
Among the largest hedge funds holding Tandem Diabetes Care’s share is Eminence Capital LLC. It holds Tandem Diabetes Care’s shares valued at 153M.
---
Tandem Diabetes Care Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€30.54 (-4.74% Downside)
€30.54 (-4.74% Downside)
Blogger Sentiment
Bullish
DE:TD5A Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $29.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.66%
12-Months-Change
Fundamentals
Return on Equity
-59.08%
Trailing 12-Months
Asset Growth
-9.51%
Trailing 12-Months
Company Description
Tandem Diabetes Care
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
---
TD5A Earnings Call
Q4 2024
0:00 / 0:00
---
TD5A Stock 12 Months Forecast
Average Price Target
€30.54
▼(-4.74% Downside)
Technical Analysis
Best Analysts Covering TD5A
1 Year
1 Year Success Rate
21/26 ratings generated profit
1 Year Average Return
+135.03%
reiterated a buy rating 8 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 80.77% of your transactions generating a profit, with an average return of +135.03% per trade.
---